Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Paneesha

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bone Marrow Transplantation|August 18, 2018
Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemiaA Kanellopoulos, M Kaparou, E Xenou, et al.
Thrombosis and Haemostasis|December 22, 2009
Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinicsS Paneesha, A McManus, R Arya, et al.
Blood Cancer Journal|July 31, 2021
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemiaH Parry, G McIlroy, R Bruton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trialA K McMillan, E H Phillips, A A Kirkwood, et al.
Leukemia Research|February 12, 2013
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplantE Nikolousis, S Robinson, S Nagra, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bone Marrow Transplantation|August 18, 2018
Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemiaA Kanellopoulos, M Kaparou, E Xenou, et al.
Thrombosis and Haemostasis|December 22, 2009
Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinicsS Paneesha, A McManus, R Arya, et al.
Blood Cancer Journal|July 31, 2021
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemiaH Parry, G McIlroy, R Bruton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trialA K McMillan, E H Phillips, A A Kirkwood, et al.
Leukemia Research|February 12, 2013
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplantE Nikolousis, S Robinson, S Nagra, et al.
Pageof 2